Estimate Recalculated Jun 13, 2025 08:26PM EST
James Darecca does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HAEMONETICS CORP, Actavis plc, TherapeuticsMD, Inc., Prestige Consumer Healthcare Inc., and Actavis, Inc..
James Darecca's CIK is 0001583903
2020 was James Darecca's most active year for acquiring shares with 5 total transactions. James Darecca's most active month to acquire stocks was the month of February. 2017 was James Darecca's most active year for disposing of shares, totalling 7 transactions. James Darecca's most active month to dispose stocks was the month of February. 2020 saw James Darecca paying a total of $699,956.24 for 1,609,611 shares, this is the most they've acquired in one year. In 2020 James Darecca cashed out on 20,213 shares for a total of $137,820.10, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!